In this episode of NETCast, which was taped live during NANETS' Cleveland NET Regional Educational Conference, leading NET medical experts held a discussion of Hormonal Management of NETs: Syndromes and Symptom Control, moderated by Amr Mohamed, MD, UH Seidman Cancer Center, University Hospital, and guests Lauren Fishbein, MD, PhD, University of Colorado, and Thorvardur Halfdanarson, MD, Mayo Clinic. Dr. Mohamed, who also served as Course Director for the NET Regional, is a medical oncologist at UH Hospitals Seidman Cancer Center, focusing on development of targeted therapies for patients with GI cancers, especially neuroendocrine tumors and colorectal cancer. Dr. Fishbein's research interests are to understand what causes neuroendocrine tumors to form (pheochromocytomas, paragangliomas, gastrointestinal and pancreatic neuroendocrine tumors). She is particularly interested in studying the inherited and tumor specific genetic changes that lead to tumor formation. Dr. Halfdanarson specializes in GI oncology. He is the program director for the Hematology/Oncology Fellowship Program at Mayo Clinic and is the current VP of the North American Neuroendocrine Tumor Society. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.